BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33428982)

  • 1. Surveillance testing reveals a significant proportion of hospitalized patients with SARS-CoV-2 are asymptomatic.
    Arnold FW; Bishop S; Oppy L; Scott L; Stevenson G
    Am J Infect Control; 2021 Mar; 49(3):281-285. PubMed ID: 33428982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections.
    Stadler RN; Maurer L; Aguilar-Bultet L; Franzeck F; Ruchti C; Kühl R; Widmer AF; Schindler R; Bingisser R; Rentsch KM; Pargger H; Sutter R; Steiner L; Meier C; Kübler W; Hirsch HH; Egli A; Battegay M; Bassetti S; Tschudin-Sutter S
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):44. PubMed ID: 33640031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.
    Yassa M; Yirmibes C; Cavusoglu G; Eksi H; Dogu C; Usta C; Mutlu M; Birol P; Gulumser C; Tug N
    J Matern Fetal Neonatal Med; 2020 Nov; 33(22):3820-3826. PubMed ID: 32691641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study.
    Zhang S; Guo M; Wu F; Xiong N; Ma Y; Wang Z; Duan L; Chen L; Ouyang H; Jin Y
    Clin Microbiol Infect; 2020 Dec; 26(12):1670-1675. PubMed ID: 32911080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.
    Scheier T; Schibli A; Eich G; Rüegg C; Kube F; Schmid A; Karrer U; Wolfensberger A; Sax H; Schreiber PW
    Emerg Infect Dis; 2021 Feb; 27(2):404-410. PubMed ID: 33395382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women.
    Cruz-Lemini M; Ferriols Perez E; de la Cruz Conty ML; Caño Aguilar A; Encinas Pardilla MB; Prats Rodríguez P; Muner Hernando M; Forcen Acebal L; Pintado Recarte P; Medina Mallen MDC; Perez Perez N; Canet Rodriguez J; Villalba Yarza A; Nieto Velasco O; Del Barrio Fernandez PG; Orizales Lago CM; Marcos Puig B; Muñoz Abellana B; Fuentes Ricoy L; Rodriguez Vicente A; Janeiro Freire MJ; Alferez Alvarez-Mallo M; Casanova Pedraz C; Alomar Mateu O; Lesmes Heredia C; Wizner de Alva JC; Posadas San Juan A; Macia Badia M; Alvarez Colomo C; Sanchez Muñoz A; Pratcorona Alicart L; Alonso Saiz R; Lopez Rodriguez M; Barbancho Lopez MC; Meca Casbas MR; Vaquerizo Ruiz O; Moran Antolin E; Nuñez Valera MJ; Fernandez Fernandez C; Tubau Navarra A; Cano Garcia AM; Soldevilla Perez S; Gattaca Abasolo I; Adanez Garcia J; Puertas Prieto A; Ostos Serna R; Guadix Martin MDP; Catalina Coello M; Espuelas Malon S; Sainz Bueno JA; Granell Escobar MR; Cruz Melguizo S; Martinez Perez O; On Behalf Of The Spanish Obstetric Emergency Group
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33467629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization.
    Fassett MJ; Lurvey LD; Yasumura L; Nguyen M; Colli JJ; Volodarskiy M; Gullett JC; Braun D; Fong A; Trivedi N; Bruxvoort K; Chiu V; Getahun D
    Am J Perinatol; 2020 Sep; 37(11):1110-1114. PubMed ID: 32620022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection in asymptomatic healthcare workers at a clinic in Chile.
    Olmos C; Campaña G; Monreal V; Pidal P; Sanchez N; Airola C; Sanhueza D; Tapia P; Muñoz AM; Corvalan F; Hurtado S; Meneses C; Orellana A; Montecino M; Arriagada G; Bustos FJ
    PLoS One; 2021; 16(1):e0245913. PubMed ID: 33507981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrated Strategy for the Prevention of SARS-CoV-2 Infection in Healthcare Workers: A Prospective Observational Study.
    Cattelan AM; Sasset L; Di Meco E; Cocchio S; Barbaro F; Cavinato S; Gardin S; Carretta G; Donato D; Crisanti A; Trevenzoli M; Baldo V
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32785110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.
    Ferreira VH; Chruscinski A; Kulasingam V; Pugh TJ; Dus T; Wouters B; Oza A; Ierullo M; Ku T; Majchrzak-Kita B; Humar ST; Bahinskaya I; Pinzon N; Zhang J; Heisler LE; Krzyzanowski PM; Lam B; Lungu IM; Manase D; Pace KM; Mashouri P; Brudno M; Garrels M; Mazzulli T; Cybulsky M; Humar A; Kumar D
    PLoS One; 2021; 16(2):e0247258. PubMed ID: 33592074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.
    Bender WR; Hirshberg A; Coutifaris P; Acker AL; Srinivas SK
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100226. PubMed ID: 32954248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Psychological Experience of Obstetric Patients and Health Care Workers after Implementation of Universal SARS-CoV-2 Testing.
    Bender WR; Srinivas S; Coutifaris P; Acker A; Hirshberg A
    Am J Perinatol; 2020 Oct; 37(12):1271-1279. PubMed ID: 32757185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Almadhi MA; Abdulrahman A; Sharaf SA; AlSaad D; Stevenson NJ; Atkin SL; AlQahtani MM
    Int J Infect Dis; 2021 Apr; 105():656-661. PubMed ID: 33647516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.
    Savirón-Cornudella R; Villalba A; Zapardiel J; Andeyro-Garcia M; Esteban LM; Pérez-López FR
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():400-404. PubMed ID: 33285496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.
    Kociolek LK; Muller WJ; Yee R; Dien Bard J; Brown CA; Revell PA; Wardell H; Savage TJ; Jung S; Dominguez S; Parikh BA; Jerris RC; Kehl SC; Campigotto A; Bender JM; Zheng X; Muscat E; Linam M; Abuogi L; Smith C; Graff K; Hernandez-Leyva A; Williams D; Pollock NR
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33093026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged persistence of PCR-detectable virus during an outbreak of SARS-CoV-2 in an inpatient geriatric psychiatry unit in King County, Washington.
    Corcorran MA; Olin S; Rani G; Nasenbeny K; Constantino-Shor C; Holmes C; Quinnan-Hostein L; Solan W; Snoeyenbos Newman G; Roxby AC; Greninger AL; Jerome KR; Neme S; Lynch JB; Dellit TH; Cohen SA
    Am J Infect Control; 2021 Mar; 49(3):293-298. PubMed ID: 32827597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.